Walgreens Boots Alliance Inc (WBA) Stake Boosted by Raymond James Financial Services Advisors Inc.
Raymond James Financial Services Advisors Inc. lifted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 249,811 shares of the pharmacy operator’s stock after purchasing an additional 11,860 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $19,292,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also modified their holdings of the company. Hudock Capital Group LLC grew its stake in shares of Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the period. Westside Investment Management Inc. grew its stake in shares of Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares during the period. IHT Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares during the period. Bristlecone Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $135,000. Finally, Private Vista LLC grew its stake in shares of Walgreens Boots Alliance by 6,403.7% during the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after purchasing an additional 574,218 shares during the period. 61.41% of the stock is owned by institutional investors and hedge funds.
A number of research analysts recently issued reports on the company. Deutsche Bank assumed coverage on Walgreens Boots Alliance in a research note on Monday, December 4th. They set a “hold” rating and a $78.00 price objective for the company. Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Leerink Swann downgraded Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 1st. Finally, Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, October 26th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $86.47.
Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.72 on Thursday. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The firm has a market capitalization of $71,030.00, a price-to-earnings ratio of 14.09, a P/E/G ratio of 1.28 and a beta of 1.22. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same quarter in the prior year, the firm posted $1.07 EPS. Walgreens Boots Alliance’s quarterly revenue was up 5.3% compared to the same quarter last year. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.23%. Walgreens Boots Alliance’s payout ratio is presently 42.33%.
Walgreens Boots Alliance declared that its Board of Directors has approved a stock buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.